1. Selenium-doped hydroxyapatite biopapers with an anti-bone tumor effect by inducing apoptosis
- Author
-
Yun-Hao Qin, Junjian Liu, Feng Chen, Ying-Ying Jiang, Jin Wu, Shi-Sheng He, Yang Zhang, Tuan-Wei Sun, Zifei Zhou, and Ying-Jie Zhu
- Subjects
Paper ,Stromal cell ,Biomedical Engineering ,Antineoplastic Agents ,Apoptosis ,Bone Neoplasms ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Mice ,Selenium ,In vivo ,Cell Line, Tumor ,Animals ,Humans ,General Materials Science ,STAT3 ,Caspase ,Membrane Potential, Mitochondrial ,chemistry.chemical_classification ,Reactive oxygen species ,biology ,Nanowires ,021001 nanoscience & nanotechnology ,Xenograft Model Antitumor Assays ,In vitro ,0104 chemical sciences ,Cell biology ,Durapatite ,chemistry ,Cell culture ,biology.protein ,0210 nano-technology - Abstract
One-dimensional hydroxyapatite (HA) particularly mimics the structure of mineralized collagen fibrils and displays superior mechanical properties such as toughness. Herein, we report Se-doped HA/chitosan (Se-HA/CS) biopapers constructed with self-assembled Se-doped HA nanowires and chitosan. The Se-HA/CS biopapers with high flexibility and manufacturability can not only be further processed into arbitrary shapes by folding or using scissors but also display high performances in in vitro/vivo anti-bone tumor studies. The Se-HA/CS biopapers are more inclined to inhibit the growth of tumor cells (HCS 2/8 and SJSA cells) than that of normal human bone marrow stromal cells (hBMSCs). The potential mechanisms of this meaningful anti-tumor effect were investigated, such as reactive oxygen species accumulation and the activation of apoptosis and the underlying signal pathway involved (including caspase family, Bcl-2 family and JNK/STAT3). The results demonstrate that Se-HA/CS biopapers may inhibit the growth of HCS 2/8 and SJSA cells by synchronously inducing JNK activation and STAT3 inhibition and consequently promote the apoptosis of these cells. Furthermore, the in vivo anti-tumor studies confirm that the Se-HA/CS biopapers obviously suppress the growth of patient-derived xenograft tumor models.
- Published
- 2019
- Full Text
- View/download PDF